Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warfarin versus aspirin for prevention of thromboembolism after total cavopulmonary operation
RBR-4z9wdgCompleted
- Sponsor
- HCor
- Start
- Jan 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of warfarin and aspirin in thrombosis (2 arms), sponsored by HCor. Primary endpoint: Prevention of thromboembolism after total cavopulmonary operation. Started Jan 2011; status: completed.
02
Drugs
warfarinaspirin
03
Conditions
thrombosis
Beyond the preview
Go deeper on RBR-4z9wdg.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4z9wdg.